Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,342 | $2,082 | $1,853 | $1,580 |
| % Growth | 12.4% | 12.4% | 17.3% | – |
| Cost of Goods Sold | $741 | $601 | $567 | $428 |
| Gross Profit | $1,600 | $1,482 | $1,287 | $1,152 |
| % Margin | 68.3% | 71.1% | 69.4% | 72.9% |
| R&D Expenses | $286 | $256 | $220 | $166 |
| G&A Expenses | $157 | $128 | $109 | $84 |
| SG&A Expenses | $654 | $601 | $572 | $481 |
| Sales & Mktg Exp. | $498 | $473 | $463 | $396 |
| Other Operating Expenses | $21 | $67 | $0 | -$1 |
| Operating Expenses | $961 | $924 | $792 | $647 |
| Operating Income | $639 | $558 | $437 | $490 |
| % Margin | 27.3% | 26.8% | 23.6% | 31% |
| Other Income/Exp. Net | -$92 | -$67 | -$36 | -$27 |
| Pre-Tax Income | $547 | $491 | $401 | $463 |
| Tax Expense | $131 | $102 | $89 | $77 |
| Net Income | $417 | $389 | $312 | $386 |
| % Margin | 17.8% | 18.7% | 16.9% | 24.4% |
| EPS | 2.02 | 1.86 | 1.52 | 1.87 |
| % Growth | 8.6% | 22.4% | -18.7% | – |
| EPS Diluted | 1.99 | 1.86 | 1.49 | 1.85 |
| Weighted Avg Shares Out | 206 | 209 | 206 | 206 |
| Weighted Avg Shares Out Dil | 209 | 209 | 209 | 209 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $82 | $75 | $34 | $21 |
| Depreciation & Amortization | $167 | $143 | $126 | $98 |
| EBITDA | $796 | $709 | $559 | $578 |
| % Margin | 34% | 34% | 30.2% | 36.6% |